From July 20-22, 2024, the "2024 Chinese Pharmaceutical Strategy Conference and the Establishment Ceremony of the Chinese Biopharmaceutical Industry-Education Integration Community" was held in Nanjing, jointly organized by the China Pharmaceutical Industry Information Center and China Pharmaceutical University.

        2024 is a critical year for implementing the “14th Five-Year Plan”, and also a key period for creating a new chapter of high-quality development in China’s modernization. General Secretary Xi Jinping said: “Technological innovation can foster new industries, models, and momentum, and is a core element in developing high-quality productivity.”

        The biopharmaceutical industry is an important component of new productive forces. This conference focuses on the forefront of global technology, the main economic battlefield, major national needs, and people’s health. It aims to achieve deep integration in education, science and technology, and talent development, thereby promoting the development of the biopharmaceutical industry. During the conference, the “2024 China Innovative Pharmaceutical Companies” list was officially released, and Haisco Medicine Group made it onto the list.